Table 1.
Treatment history and the changes of liver biochemical markers
| Date | Treatment | ALT(U/L) (5-40) |
AST(U/L) (5-37) |
GGT(U/L) (10-67) |
TB(μmol/L) (5.1-22.2) |
DB(μmol/L) (0-8.6) |
ALP(U/L) (30-120) |
Symptoms |
|---|---|---|---|---|---|---|---|---|
| 2012-4-12 | ZOL infusion (5 mg) | 33 | 15 | 45 | 9.8 | 2.6 | 77 | Fever 38.7 °C, myalgia, arthralgia |
| 2012-4-15 | glucurolactone (100 mg 3/d), polyene ) | 254 | 73 | 135 | 6.3 | 2.4 | – | |
| 2014-4-18 | phosphatidylcholine (456 mg 3/d | 126 | 43 | 112 | 7.7 | 2.5 | 118 | |
| 2012-4-21 | 66 | 40 | - | 11.2 | 4.3 | – | ||
| 2013-5-7 | ZOL infusion (5 mg), glucurolactone (100 mg 3/d) | 28 | 18 | 30 | 9.6 | 2.9 | 44 | Fever 38.0 °C, arthralgia |
| 2013-5-10 | 70 | 40 | 46 | 4.6 | 1.6 | - | ||
| 2013-5-13 | 48 | 22 | 43 | 6.0 | 2.1 | 58 | ||
| 2014-6-22 | ZOL infusion (5 mg), glucurolactone (100 mg 3/d) | 24 | 20 | 27 | 7.2 | 2.4 | 51 | No fever or pain |
| 2014-6-25 | 31 | 28 | 33 | 5.9 | 1.6 | 55 |
ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyltransferase, TB total bilirubin, DB direct bilirubin, ALP alkaline phosphatase